Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Progressive Multiple Sclerosis: early-phase trial registry
2 of 4 indexed Progressive Multiple Sclerosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Progressive Multiple Sclerosis: 4 US clinical trials tracked, 2 recruiting.
Progressive Multiple Sclerosis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Bruce Cree, running 1 of these trials.
Enrollment posture brief
Registry condition progressive-multiple-sclerosis
OPEN 2 | RECR 50% | LATE 0 | EARLY 3 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Progressive Multiple Sclerosis lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Progressive Multiple Sclerosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Progressive Multiple Sclerosis is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
University of Michigan
NCT07392879
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Autolus Limited
NCT07139743
ABA-101 in Participants With Progressive Multiple Sclerosis
Abata Therapeutics
NCT06566261
A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis
Bruce Cree
NCT06451159
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Progressive Multiple Sclerosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Progressive Multiple Sclerosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Progressive Multiple Sclerosis page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Progressive Multiple Sclerosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bruce Cree sponsors the most Progressive Multiple Sclerosis trials on record, review their full trial history before evaluating a specific study. See Bruce Cree's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Progressive Multiple Sclerosis condition card totals 4 registered trials; most-linked intervention Chemotherapy: fludarabine (FLU); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.